Barcelona, 15 April 2026 – Global life science company Bioiberica is set to return to Vitafoods Europe to showcase its ongoing commitment to empowering the health evolution through its flagship portfolio of low dose science-backed branded ingredients. At booth #5B28, Bioiberica will spotlight a freshly published clinical trial for its native (undenatured) type II collagen ingredient, Collavant® n2, demonstrating cartilage support benefits measured by CTX-II biomarkers in healthy individuals for the first time.[1] Visitors are also invited to experience an industry-first collagen-fortified milk drink at Bioiberica’s low dose coffee corner, where the team will unveil cutting-edge prototype concepts to inspire the next wave of wellness solutions for mobility, skin and digestive health.
Spotlighting new science
Collavant® n2 will take center stage at the Nutraceuticals Showcase Theatre on Wednesday 6 May at 2:30pm for a presentation entitled: “New opportunities in collagen: Breakthrough science, mobility insights and inspiring functional food formats.” Attendees can learn more about Bioiberica’s recently published clinical trial, which suggests that Collavant® n2 (40 mg/day) helps to reduce exercise-related joint discomfort, supporting mobility, quality of life and cartilage health at a structural level, measured by CTX-II biomarkers.[2] These results mark the first time such benefits have been demonstrated in healthy subjects, signaling a major opportunity for collagen brands looking to develop products for active, health-conscious consumers seeking proactive joint support. Additionally, the company will spotlight a recent randomized clinical trial for Dermial®, its industry-first hyaluronic acid (HA) matrix ingredient, demonstrating the ingredient’s skin health benefits and its unique ‘glow’ effect at only 60 mg /day.
Inspiring low-dose ingredient innovation
Visitors are invited to head to Bioiberica’s ‘Low dose coffee corner’, where they can enjoy a coffee fortified with Puleva Vita Calcio Colágeno – a first-of-its-kind milk beverage from Lactalis Spain made with Collavant® n2 alongside other nutrients for joint health. Beyond collagen, Bioiberica’s formulation experts will also be on hand to spotlight prototype concepts including water, soft drinks, gummies and yoghurt fortified with its wider portfolio of branded ingredients and low-dose innovative supplement product concepts including hyaluronic acid (HA) matrix ingredients Dermial® (60 mg/day) for skin health and Mobilee® (80 mg/day) for muscle and joint support, as well as DAOgest® (4.2mg/serving), a premium diamine oxidase (DAO) enzyme for histamine intolerance. Together, Bioiberica’s complete branded ingredients portfolio reinforces the company’s leadership in science-led innovation, aligning with the industry’s strongest growth drivers such as longevity, women’s health and nutricosmetics.
Premiering pet nutrition solutions
Vitafoods Europe 2026 marks a first for Bioiberica as the company brings its breakthrough ingredients to the Pet Nutrition Hub. With the pet food market beginning to adopt many of the same health-and-wellness trends seen in human nutrition, Bioiberica’s science-backed pet health ingredients are here to help brands tap into the 2.76 billion-dollar pet supplement market – which is predicted to grow to $4.65 billion by 2033.[3]
Meet Bioiberica at Vitafoods Europe 2026
“We’re excited to welcome Vitafoods Europe back to our home city in Barcelona to showcase the expertise that defines us as a global leader in the health and nutrition space – leveraging science and circular economy production to empower the next stage of the health evolution”, says Antonio Vendrell, Marketing & Communications Director at Bioiberica. “With more than 50 years of expertise in the world-class manufacturing of biologically-derived ingredients, this year our focus is on showcasing how we can support our partners in overcoming formulation challenges, enabling brands to elevate their dietary supplements offering and inspire the next generation of functional foods and beverages.”
For more information about Bioiberica’s human health portfolio, or to schedule a meeting with the team at Vitafoods Europe, please visit: www.bioiberica.com
[1] Möller, I. et al. Effect of Native (undenatured) Type-ii Collagen in CTX-II Biomarker: Results from a Randomized Double-blind Placebo-controlled Study in Healthy Subjects with Joint Discomfort. Journal of the Academy of Nutrition and Dietetics 125, A73 (2025).
[2] Möller, I. et al. Effect of Native (undenatured) Type-ii Collagen in CTX-II Biomarker: Results from a Randomized Double-blind Placebo-controlled Study in Healthy Subjects with Joint Discomfort. Journal of the Academy of Nutrition and Dietetics 125, A73 (2025).
[3] Pet Supplements Market Size, Share | Industry Report, 2033
